November 3, 2021
Diversity is inextricably tied to the success of the NIH mission, thus ensuring diversity within the extramural biomedical research workforce is of utmost importance. We are aware that NIH’s recent decision to rescind a “Notice of Special Interest” (or NOSI) – intended solely to call attention to the presence of a specific funding opportunity announcement and encourage researchers from underrepresented groups to apply – may have caused some to question this commitment. While the spirit of the NOSI was laudable, it may have led to an impression that by linking demographic characteristics to grant proposals, applications supporting scientists from underrepresented groups would be automatically prioritized for funding. Read on for more.
June 1, 2021
In a previous post, we looked at the gender distribution of designated principal investigators (PI’s) of R01 and RPG applications submitted before and after the onset of the COVID-19 pandemic. Here we look at NIH R01 and RPG application patterns for January 1 through April 8 over the past 6 years; these applications patterns may well reflect longer-term pandemic effects.
March 8, 2021
On March 1, NIH Director Francis Collins announced NIH’s broad-based initiative, UNITE, to end structural racism and racial inequities in biomedical science. This is a recognition of the need for urgent, sustained effort on many fronts across the research enterprise, including in all parts of the NIH’s extramural processes, to change culture. While the NIH Institutes and Centers will examine their programmatic priorities and discretionary funding practices, here at CSR, we are committed to pushing ahead with efforts to protect the peer review process from the systemic biases that exist in all areas of the scientific community.
March 1, 2021
I am proud to join my NIH colleagues today in reaffirming our commitment to fostering a diverse biomedical research workforce and ending structural racism at NIH, the institutions we support, and anywhere where NIH research activities take place. Working together, we can continue identifying and dismantling any policies, practices, or other impediments that may harm our supported workforce and science. We encourage you to join us in this effort. Please take a moment to read the statement below from the NIH Director on achieving racial equity in biomedical research and visit our new webpage, which includes more on the UNITE initiative. You are also welcome to share your thoughts and ideas to our Request for Information directly with us here.
January 22, 2021
At NIH, we have and continue to focus not just on gender equity but on ensuring greater diversity in all aspects of the biomedical workforce. This means, that along with women, members of racial and/or ethnic minority groups, people with disabilities, and those from disadvantaged backgrounds are also included. To help ensure that the nation remains a global leader in scientific discovery and innovation, NIH needs the richness and breadth of varied perspectives that comes from having a pool of highly talented scientists from diverse backgrounds.
In that spirit, today we released a guide notice (NOT-OD-21-053) that updates guidance for NIH R13/U13 Conference Grant applicants and recipients.
May 27, 2020
NIH is seeking applications for the 2021 Transformative Research awards through a new funding opportunity (RFA-RM-20-013) recently released on Friday, May 21, 2020. And, as a way to address concerns about bias in peer review while also enhancing diversity, this High Risk, High Reward program is going to anonymize the review of Transformative Research Award applications.
November 26, 2019
NIH has considered a different approach to defining scientists from disadvantaged backgrounds. We reviewed a wide variety of criteria, looking for those that are relatively easy to self-evaluate and that capture a large proportion of affected people.
October 10, 2019
In a paper recently published in Science Advances, we delved into the underlying factors associated with the funding gap between white and black researchers. We identified three decision points where disparate outcomes arose between white and black researchers: 1) the decision to bring applications to discussion during peer review study section meetings; 2) impact score assignments for those applications brought to discussion; and (3) a previously unstudied factor, topic choice – that is what topic the investigators chose to study.
July 22, 2019
Inviting women to speak at conferences matters for many reasons – it’s a matter of fairness; it gives eminently qualified women a level playing field; it is just the right thing to do. In essence, it’s about changing the fundamental culture of the biomedical research enterprise to allow full participation from people of all backgrounds. In that vein, I’d like to remind you that if you are applying for an R13 conference grant from NIH, please be sure to read the requirements in the Funding Opportunity Announcement, where meeting diversity is a long-standing expectation.
August 7, 2018
As highlighted in many previous blog posts and the recent National Academies of Sciences, Engineering, and Medicine (NASEM) report, promoting a strong biomedical workforce is a top priority for the NIH. In 2017, NIH launched the Next Generation Researchers Initiative, which is a multi-pronged approach to increase the number of NIH-funded early stage investigators. An important component of this initiative is the call for increased transparency and availability of data about the make-up of the biomedical research workforce. More complete data will allow NIH leadership to best understand and address the needs of our emerging workforce.
3 Comments